Table 1 Participants’ demographics information
Parti. | Gender | Age | Level of injury | ASIA | Years since SCI | Pain intensity (VNS) | Medication |
|---|---|---|---|---|---|---|---|
P1 | M | 62 | L3/L4 | D | 9 | 10 | Pregabalin |
P2 | M | 51 | T6/T7 | D | 7 | 7 | Gabapentin |
P3 | F | 56 | T5 | D | 3 | 7 | Tramadol |
P4 | M | 64 | T4 | A | 7 | 6 | Tramadol |
P5 | M | 66 | L3 | D | 5 | 5 | / |
P6 | M | 59 | C2 | B | 5 | 8 | Pregabalin |
P7 | M | 59 | C2 | A | 7 | 5 | / |
P8 | M | 50 | C3/C5 | D | 3 | 5 | / |
P9 | F | 54 | T5 | A | 7 | 5 | Pregabalin |
P10 | M | 35 | C4 | D | 15 | 10 | Gabapentin |
P11 | M | 42 | C2 | A | 1 | 4–5 | Gabapentin |
P12 | M | 49 | T6 | B | 1 | 5 | Duloxetine |
P13 | F | 21 | Â | D | 10 | 6 | / |
P14 | F | 54 | C6/C7 | A | 5 | 6 | / |
P15 | M | 58 | T6/T7 | A | 30 | 9–10 | Nabline |
P16 | M | 18 | L3/4 | D | 7 | 4 | / |
P17 | M | 42 | C5-C7 | A | 15 | 6 | Baclofen/ Pregabalin |
P18 | M | 58 | L4 | A | 21 | 6 | Baclofen/ Pregabalin |
P19 | M | 42 | L2 | A | 13 | 7 | / |
P20 | M | 72 | T10 | A | 1 | 8 | Baclofen |